YU6102A - Farmaceutski preparat i njegova primena - Google Patents

Farmaceutski preparat i njegova primena

Info

Publication number
YU6102A
YU6102A YU6102A YUP6102A YU6102A YU 6102 A YU6102 A YU 6102A YU 6102 A YU6102 A YU 6102A YU P6102 A YUP6102 A YU P6102A YU 6102 A YU6102 A YU 6102A
Authority
YU
Yugoslavia
Prior art keywords
pharmaceutical composition
preparation
active ingredient
additional active
oneor
Prior art date
Application number
YU6102A
Other languages
English (en)
Inventor
Morvai Magdalena Vitanyine
Peterne Kovacs
Mathe Irma Kalmanne
Boglarka Jakab
Erzebet Vegeli
Original Assignee
Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. filed Critical Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt.
Priority to MEP-185/08A priority Critical patent/MEP18508A/xx
Publication of YU6102A publication Critical patent/YU6102A/sh
Publication of RS50074B publication Critical patent/RS50074B/sr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Pronalazak se odnosi na stabilan, čvrsti farmaceutski preparat koji kao aktivne sastojke sadrži paracetamol i drotaverin hidrohlorid u mešavini sa jednom ili više organskih kiselina ili kalijum sorbatom kao stabilizatorima, jednim ili više uobičajeno korišćenih farmaceutskih pomoćnih materijala i po potrebi dodatni aktivni sastojak. Kao dodatni aktivni sastojak može biti upotrebljen kodein fosfat.[The invention relates to a stable, solid pharmaceutical composition comprising as active ingredients paracetamol and drotaverine hydrochloride in a mixture with one or more organic acid or potassium sorbate as stabilizers, oneor more usually used pharmaceutical auxiliary materials and optionally additional active ingredient. As additional active ingredient codein phosphate may be used.
YUP-61/02A 1999-07-28 2000-07-28 Farmaceutski preparat koji sadrži paracetamol i drotaverin RS50074B (sr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MEP-185/08A MEP18508A (en) 1999-07-28 2000-07-28 Pharmaceutical composition and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU9902559A HU225779B1 (en) 1999-07-28 1999-07-28 Pharmaceutical composition containing paracetamol and drotaverine and process for producing it

Publications (2)

Publication Number Publication Date
YU6102A true YU6102A (sh) 2005-03-15
RS50074B RS50074B (sr) 2009-01-22

Family

ID=90014235

Country Status (19)

Country Link
EP (1) EP1200088B1 (sh)
AT (1) ATE241983T1 (sh)
AU (1) AU6308800A (sh)
BG (1) BG65553B1 (sh)
DE (1) DE60003188T2 (sh)
DK (1) DK1200088T3 (sh)
EA (1) EA003779B1 (sh)
EE (1) EE04952B1 (sh)
ES (1) ES2197107T3 (sh)
GE (1) GEP20053581B (sh)
HR (1) HRP20020071B1 (sh)
HU (1) HU225779B1 (sh)
ME (2) ME00088B (sh)
PL (1) PL197749B1 (sh)
PT (1) PT1200088E (sh)
RS (1) RS50074B (sh)
SI (1) SI1200088T1 (sh)
UA (1) UA72535C2 (sh)
WO (1) WO2001007024A2 (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY29527A1 (es) 2005-05-13 2006-12-29 Schering Ag Composicinn farmaccutica que contienen gestrgenos y/o estrngenos y 5-metil - (6s) - tetrhidrofolato.
RU2704613C2 (ru) * 2014-11-11 2019-10-30 Д-Р Редди'С Лабораторис Лимитед Фармацевтические препараты с фиксированной комбинацией доз обезболивающего и антиспазматического агентов
EP3520781A1 (en) * 2018-02-05 2019-08-07 Adamed sp. z o.o. A pharmaceutical composition comprising metamizole, drotaverine, and caffeine
BR112022017998A2 (pt) * 2020-03-09 2022-10-25 Paul Berlia Sushma Formulações de liberação controlada compreendendo drotaverina ou sal da mesma
CN115397411A (zh) * 2020-04-23 2022-11-25 浙江养生堂天然药物研究所有限公司 药物组合及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3830353A1 (de) * 1988-09-07 1990-03-15 Basf Ag Verfahren zur kontinuierlichen herstellung von festen pharmazeutischen formen
US5348745A (en) * 1989-05-09 1994-09-20 Miles Inc. Aqueous granulation solution and a method of tablet granulation

Also Published As

Publication number Publication date
EA003779B1 (ru) 2003-08-28
EE200200042A (et) 2003-04-15
HUP9902559D0 (en) 1999-10-28
EA200200211A1 (ru) 2002-08-29
BG65553B1 (bg) 2008-12-30
PL197749B1 (pl) 2008-04-30
HU225779B1 (en) 2007-08-28
HRP20020071B1 (en) 2011-01-31
DE60003188T2 (de) 2004-07-01
ATE241983T1 (de) 2003-06-15
AU6308800A (en) 2001-02-13
PT1200088E (pt) 2003-10-31
PL353209A1 (en) 2003-11-03
WO2001007024A2 (en) 2001-02-01
GEP20053581B (en) 2005-07-25
SI1200088T1 (en) 2003-12-31
EP1200088A2 (en) 2002-05-02
ME00088B (me) 2010-10-10
WO2001007024A3 (en) 2001-03-29
DE60003188D1 (de) 2003-07-10
EP1200088B1 (en) 2003-06-04
EE04952B1 (et) 2008-02-15
HUP9902559A2 (hu) 2002-04-29
HUP9902559A3 (en) 2003-05-28
MEP18508A (en) 2010-06-10
UA72535C2 (en) 2005-03-15
ES2197107T3 (es) 2004-01-01
BG106368A (en) 2002-08-30
HRP20020071A2 (en) 2003-12-31
DK1200088T3 (da) 2003-09-22
RS50074B (sr) 2009-01-22

Similar Documents

Publication Publication Date Title
WO2000040203A3 (en) Polymeric delivery agents and delivery agent compounds
WO2000007979A3 (en) Compounds and compositions for delivering active agents
ME00298B (me) Farmaceutski preparat
WO2004033418A3 (en) Sulfonylamino-acetic derivatives and their use as orexin receptor antagonists
HUP0203528A3 (en) Piperidine derivatives useful as ccr5 antagonists, pharmaceutical compositions containing them and their use
WO2001032596A8 (en) Phenoxy carboxylic acid compounds and compositions for delivering active agents
CA2338358A1 (en) Compounds and compositions for delivering active agents
HUP0303653A3 (en) Tricyclic and heterocyclic derivative and pharmaceutical compositions containing them as the active ingredient
WO2003045306A3 (en) Phenoxy amine compounds and compositions for delivering active agents
WO2004026836A3 (en) 1-pyridin-4-yl-urea derivatives
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
WO2002015959A3 (en) Compounds and compositions for delivering active agents
AU2001228811A1 (en) Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
WO2000010526A3 (en) New oral formulation for 5-ht4 agonists or antagonists
AU2001278772A1 (en) Benzoic acid derivatives and drugs containing the same as the active ingredient
HUP0102369A3 (en) Amino acid derivatives and drugs containing the same as the active ingredient
WO2002015933A3 (en) Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
AU2001234107A1 (en) Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient
AU2001277738A1 (en) Piperidine derivatives and drugs containing these derivatives as the active ingredient
YU6102A (sh) Farmaceutski preparat i njegova primena
AU3669700A (en) 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
AU1650501A (en) 1,3,4-oxadiazoline derivatives and drugs containing these derivatives as the active ingredient
WO2002100338A3 (en) Compound and composition for delivering active agents
AU1556601A (en) 1,3,4-oxadiazolin-2-one derivatives and drugs containing these derivatives as the active ingredient
WO2005062874A3 (en) Compounds and compositions for delivering active agents